SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

米国の薬剤溶解ステント (DESS)市場：規模、動向、予測（2021-2025年版）

米国の薬剤溶解ステント (DESS)市場：規模、動向、予測（2021-2025年版）The US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2021-2025 Edition)

このレポートへお問合せ

  
種別英文調査報告書
出版Daedal Research
出版年月2021年3月
ページ数71
図表数
価格（USD）
シングルユーザライセンス850
エンタープライズライセンス1400
 

レポート目次

  Report DetailsScope of the ReportThe report titled “The US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2021-2025 Edition)”, provides an in depth analysis of the US drug eluting sinus stent (DESS) market by value. The report also provides a detailed analysis of the US sinus surgery market by sinusitis patients, chronic sinusitis patients, number of ENT eligible patients, number of procedures, etc. The report also provides an analysis of the US Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD) market by Value and by number of procedures.The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the US drug eluting sinus stent (DESS) market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.The US drug eluting sinus stent (DESS) market is concentrated with few major market players operating in the region. The key players of the drug eluting sinus stent (DESS) market are Intersect ENT, Inc., Medtronic plc, Stryker Corporation (Entellus Medical, Inc.), and Johnson & Johnson (Acclarent, Inc.) are also profiled with their financial information and respective business strategies.Country CoverageThe USCompany CoverageIntersect ENT, Inc.Medtronic plcStryker Corporation (Entellus Medical, Inc.)Johnson & Johnson (Acclarent, Inc.)Executive SummarySinusitis can be divided into Acute Sinusitis, Recurrent Acute Rhinosinusitis (RARS) and chronic Rhinosinusitis (CRS), on the basis of the duration of the episode of sinusitis and its severity. The treatment options for the sinusitis can be over-the-counter treatment, medical management and surgery. The OTC treatment includes decongestants, antihistamines, pain relievers and nasal irrigation. Medical management includes antibiotics and oral and nasal steroids. The sinus surgeries are mainly of two types: Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD).The US drug eluting sinus stent (DESS) market has increased significantly during the years 2018-2020, and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The drug eluting sinus stent (DESS) market is expected to increase due to surging healthcare expenditure, increasing prevalence of sinus related disorders, growing treatment in physician’s office, limitations of FESS, favorable government initiatives for promoting the use of sinus stents, etc. Yet the market faces some challenges such as economic slowdown, high cost involved, use of oral steroids and packing material, etc. Table of Contents

目次

1. Executive Summary2. Introduction2.1 Sinus: An Overview2.1.1 Types of Sinus2.2 Sinusitis: An Overview2.2.1 Types of Sinusitis2.2.2 Treatment Options for Sinusitis2.3 Drug Eluting Sinus Stent (DESS): An Overview3. The US Market Analysis3.1 The US Sinus Surgery Market: An Analysis3.1.1 The US Sinus Surgery Market by Sinusitis Patients3.1.2 The US Sinus Surgery Market by Chronic Sinusitis Patients3.1.3 The US Sinus Surgery Market by Number of ENT Eligible Patients3.1.4 The US Sinus Surgery Market by Surgical and Non Surgical ENT Eligible Patients3.1.5 The US Sinus Surgery Market by Number of Procedures3.1.6 The US Sinus Surgery Market Number of Procedures by Segments (Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD)3.2 The US Functional Endoscopic Sinus Surgery (FESS) Market: An Analysis3.2.1 The US Functional Endoscopic Sinus Surgery (FESS) Market by Value3.2.2 The US Functional Endoscopic Sinus Surgery (FESS) Market by Number of Procedures3.3 The US Balloon Sinus Dilation (BSD) Market: An Analysis3.3.1 The US Balloon Sinus Dilation (BSD) Market by Value3.3.2 The US Balloon Sinus Dilation (BSD) Market by Number of Procedures3.3.3 The US Balloon Sinus Dilation (BSD) Market by Segments (operating room (OR) and Office)3.3.4 The US Operating Room (OR) Balloon Sinus Dilation (BSD) Market by Value and by Number of Procedures3.3.5 The US Office Balloon Sinus Dilation (BSD) Market by Value and by Number of Procedures3.4 The US Drug Eluting Sinus Stent (DESS) Market: An Analysis3.4.1 The US Drug Eluting Sinus Stent (DESS) Market by Value4. Market Dynamics4.1 Growth Driver4.1.1 Surging Healthcare Expenditure4.1.2 Increasing Prevalence of Sinus Related Disorders4.1.3 Growing Treatment in Physician’s Office4.1.4 Limitations of FESS4.1.5 Favorable Government Initiatives for Promoting the Use of Sinus Stents4.2 Challenges4.2.1 Economic Slowdown4.2.2 High Cost Involved4.2.3 Use of Oral Steroids and Packing Material4.3 Market Trends4.3.1 Introduction of Innovative Techniques in Sinus Surgery4.3.2 Increasing Awareness among Patients towards the Chronic Sinusitis and Sinus Surgery4.3.3 Rising Popularity of Minimally Invasive Surgeries4.3.4 Shift from FESS to BSD5. Competitive Landscape5.1 The US Drug Eluting Sinus Stent (DESS) Market Players: A Financial Comparison5.2 The US Drug Eluting Sinus Stent (DESS) Market Players by Products and Services6. Company Profiles6.1 Intersect ENT, Inc.6.1.1 Business Overview6.1.2 Financial Overview6.1.3 Business Strategy6.2 Medtronic plc6.2.1 Business Overview6.2.2 Financial Overview6.2.3 Business Strategy6.3 Stryker Corporation (Entellus Medical, Inc.)6.3.1 Business Overview6.3.2 Financial Overview6.3.3 Business Strategy6.4 Johnson & Johnson (Acclarent, Inc.)6.4.1 Business Overview6.4.2 Financial Overview6.4.3 Business StrategyList of FiguresFigure 1: Types of SinusesFigure 2: Types of SinusitisFigure 3: Treatment Options for SinusitisFigure 4: The US Sinus Surgery Market by Sinusitis Patients; 2017-2020 (Million)Figure 5: The US Sinus Surgery Market by Sinusitis Patients; 2021-2025 (Million)Figure 6: The US Sinus Surgery Market by Chronic Sinusitis Patients; 2017-2020 (Million)Figure 7: The US Sinus Surgery Market by Chronic Sinusitis Patients; 2021-2025 (Million)Figure 8: The US Sinus Surgery Market by Number of ENT Eligible Patients; 2017-2020 (Million)Figure 9: The US Sinus Surgery Market by Number of ENT Eligible Patients; 2021-2025 (Million)Figure 10: The US Sinus Surgery Market by Surgical and Non Surgical ENT Eligible Patients; 2017-2025 (Million)Figure 11: The US Sinus Surgery Market by Number of Procedures; 2017-2020 (Million)Figure 12: The US Sinus Surgery Market by Number of Procedures; 2021-2025 (Million)Figure 13: The US Sinus Surgery Market Number of Procedures by Segments; 2020 (Percentage, %)Figure 14: The US Functional Endoscopic Sinus Surgery (FESS) Market by Value; 2018-2020 (US$ Million)Figure 15: The US Functional Endoscopic Sinus Surgery (FESS) Market by Value; 2021-2025 (US$ Million)Figure 16: The US Functional Endoscopic Sinus Surgery (FESS) Market by Number of Procedures; 2017-2020 (Thousand)Figure 17: The US Functional Endoscopic Sinus Surgery (FESS) Market by Number of Procedures; 2021-2025 (Thousand)Figure 18: The US Balloon Sinus Dilation (BSD) Market by Value; 2018-2020 (US$ Million)Figure 19: The US Balloon Sinus Dilation (BSD) Market by Value; 2021-2025 (US$ Million)Figure 20: The US Balloon Sinus Dilation (BSD) Market by Number of Procedures; 2017-2020 (Thousand)Figure 21: The US Balloon Sinus Dilation (BSD) Market by Number of Procedures; 2021-2025 (Thousand)Figure 22: The US BSD Market Value by Segments; 2020 (Percentage, %)Figure 23: The US BSD Market Number of Procedures by Segments; 2020 (Percentage, %)Figure 24: The US Operating Room (OR) BSD Market by Value; 2018-2025 (US$ Million)Figure 25: The US Operating Room (OR) BSD Market by Number of Procedures; 2018-2025 (Thousand)Figure 26: The US Office BSD Market by Value; 2018-2025 (US$ Million)Figure 27: The US Office BSD Market by Number of Procedures; 2018-2025 (Thousand)Figure 28: The US Drug Eluting Sinus Stent (DESS) Market by Value; 2018-2020 (US$ Million)Figure 29: The US Drug Eluting Sinus Stent (DESS) by Value; 2021-2025 (US$ Million)Figure 30: The US Health Expenditure; 2014-2020 (US$ Trillion)Figure 31: The US Real GDP Growth; 2019-2021 (Percentage, %)Figure 32: Intersect ENT, Inc. Revenue; 2015-2019 (US$ Million)Figure 33: Intersect ENT, Inc. Revenue by Products; 2019 (Percentage, %)Figure 34: Medtronic plc Net Sales; 2015-2019 (US$ Billion)Figure 35: Medtronic plc Net Sales by Segments; 2020 (Percentage, %)Figure 36: Medtronic plc Net Sales by Region; 2020 (Percentage, %)Figure 37: Stryker Corporation Net Sales; 2016-2020 (US$ Billion)Figure 38: Stryker Corporation Net Sales by Segments; 2020 (Percentage, %)Figure 39: Stryker Corporation Net Sales by Region; 2020 (Percentage, %)Figure 40: Johnson & Johnson Sales; 2016-2020 (US$ Billion)Figure 41: Johnson & Johnson Sales by Segments; 2020 (Percentage, %)Figure 42: Johnson & Johnson Sales by Region; 2020 (Percentage, %)Table 1: The US Drug Eluting Sinus Stent (DESS) Market Players: A Financial Comparison; 2019/2020Table 2: The US Drug Eluting Sinus Stent (DESS) Market Players by Products and Services

お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    プライバシーポリシーはこちらをご覧ください。

    その他の最新記事8件